Neurotensin is an endogenous neuropeptide that has significant interactions with monoamine neurotransmitter systems. To date, neurotensin NTS 1 receptor agonists, such as PD149163, have been primarily evaluated for the treatment for schizophrenia, drug addiction, and pain. Recently, PD149163 was found to attenuate fearpotentiated startle in rats, an experimental procedure used for screening anxiolytic drugs. The present study sought to assess these findings through testing PD149163 in a conditioned footshock-induced ultrasonic vocalization (USV) model. Conditioning was conducted in male Wistar rats using chambers equipped with shock grid floors and an ultrasonic vocalization detector. PD149163 and the 5-HT 1A receptor partial agonist buspirone produced a statistically significant reduction of 22 kHz USV counts. The typical antipsychotic haloperidol also reduced 22 kHz USV counts, but did so at cataleptic doses. Ten days of repeated administration of PD149163 abolished the inhibitory effects of PD149163 on 22 kHz USVs. These findings further support an anxiolytic profile for PD149163. However, tolerance to these effects may limit the utility of these drugs for the treatment of anxiety.
Introduction
Neurotensin is an endogenous neuropeptide that is an emerging target for the treatment of anxiety. Neurotensin interacts closely with monoamine neurotransmitter systems (Binder et al., 2001; Jolas and Aghajanian, 1997) , and neurotensin receptors are densely located in structures important for anxiety and depression, including the amygdala, hippocampus, and raphe nuclei (Alexander and Leeman, 1998) . Stressinduced increases in median raphe nucleus 5-hydroxytryptophan levels (Dilts and Boadle-Biber, 1995) have been attenuated by intracerebroventricular administration of neurotensin (Dilts et al., 1996) and potentiated by systemic administration of the neurotensin NTS 1 receptor antagonist SR48692 (Corley et al., 2002) . Further, central neurotensin administration has reversed decreases in stress-related foraging in rats with lesioned serotonin neurons in the dorsal raphe nucleus (Shugalev et al., 2005) . NTS 1 receptor knockout mice have exhibited anxiety-like responses in an open field, including less time spent in the center and more time spent in the corners of the field compared to wild type mice, although differences were not shown between NTS 1 knockout and wild type mice in an elevated plus maze (Fitzpatrick et al., 2012) . Shilling and Feifel (2008) demonstrated that systemic administration of the brain penetrant neurotensin NTS 1 receptor agonist PD149163 (Petrie et al., 2004) significantly decreased fear potentiated startle in rats.
Another method for studying anxiety in rats is to record ultrasonic vocalizations (USVs) during states of fear or stress. In adult rats, 22 kHz USVs occur during fear-like postures (e.g., freezing) (Brudzynski and Chiu, 1995), avoidance behavior, and the presence of an intruder (Tornatzky and Miczek, 1994) . Twenty-two kHz USVs are also emitted immediately after footshock stimulation (Tonoue et al., 1986) and when placed in an environment previously paired with footshock (Molewijk et al., 1995; Tonoue et al., 1987) . Conditioned footshock-induced 22 kHz USVs are also suppressed by benzodiazepines (e.g., Millan et al., 2001; Molewijk et al., 1995) , 5-HT 1A receptor agonists (De Vry et al., 1993; Molewijk et al., 1995; Remy et al., 1996) , 5-HT reuptake inhibitors (Molewijk et al., 1995; Sanchez and Meier, 1997; Sanchez et al., 2003) , and antipsychotic drugs (Sun et al., 2010) .
The present study sought to further evaluate the putative anxiolytic effects of the neurotensin by testing the NTS 1 receptor agonist PD149163 on conditioned footshock-induced USVs. In addition, the effects of the 5-HT 1A receptor agonist and anxiolytic buspirone, which has been demonstrated to inhibit conditioned footshock-induced 22 kHz USVs (Brodkin et al., 2002; Molewijk et al., 1995) , were assessed for comparison. Further, the D 2 receptor-preferring antagonist (Schotte et al., 1996) and typical antipsychotic drug haloperidol was also studied 
